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most extensively analysed fungal 
sequences.
As there are now barcode 
sequences covering all kingdoms of 
multicellular life, and taxonomists in 
museums are working hard to keep 
the molecular information connected 
to the traditional repositories and 
species definitions, barcodes offer 
the opportunity to expand species 
identification to situations where 
skilled taxonomists may not be at 
hand. 
“As anyone who’s been on a 
walk with a taxonomist knows, 
their ability to rattle off the names 
of the plants and animals they see 
along the trailside is so impressive 
as to seem almost magical. 
That ability, and the knowledge 
that underpins it, is the result 
of many years if not decades 
of intensive, highly specialized 
study, and, as a result, it’s 
extremely rare,” says Karen James 
from the Mount Desert Island 
Biological Laboratory, in Maine, 
US. “DNA barcoding is a tool for 
amplifying taxonomic expertise. 
Combined with the growing popularity 
of citizen science (i.e. public 
participation in scientific research), 
DNA barcoding could enable a large 
number of non-experts, spread 
around the world, to participate in 
understanding and conserving the 
diversity of life.”
Barcoding Nemo: Supervision of the trade 
with ornamental fish is one of the applications 
of DNA barcoding. (Photo: Barcode Wales.)Ivan Dikic
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What turned you on to biology in the 
first place? In school it was a pure 
curiosity about life in nature: what it 
is, how it all started and what controls 
the cell from inside? When I decided to 
study medicine I was mostly attracted 
to the molecular basis of cellular 
processes and what goes wrong during 
disease progression.
Did your career take a turn at some 
point — if so, what was it and why did 
you make it? After finishing medical 
school I met Joseph Schlessinger. 
He offered me the opportunity to join 
his lab in New York studying protein 
tyrosine kinase signaling. I was an 
inexperienced young medical doctor 
at the time, but I felt that turning to 
molecular biology would more greatly 
satisfy my curiosity than clinical 
medicine. Moreover, it was a great 
opportunity to work with this brilliant 
scientist. I had to struggle a lot in the 
beginning but I have no regrets about 
the decision.
Q & AIf you knew earlier on what you know 
now, would you still pursue the same 
career/research path? Yes, with the 
same passion, naivety and enthusiasm. 
I would not change anything since 
I appreciate the decisions I made 
at the time. To have your entire 
career pre-planned in minute detail 
following advice from those more 
experienced appears very boring to 
me. For example, after finishing my 
postdoc I got an excellent offer from 
Columbia University for a tenure-track 
professorship in the Department of 
Pharmacology. Everybody was telling 
me that this is a unique opportunity, and 
I indeed liked the people. Yet, somehow 
my wife Inga and I decided to take a 
turn in our lives and leave the exciting 
life of Manhattan for a quiet one in 
Uppsala, where I took a position as a 
group leader in the Ludwig Institute for 
Cancer Research. We never regretted 
this decision.
What is the best advice you’ve been 
given, and what advice would you 
offer someone wondering whether to 
start a career in biology? The advice 
I got and would gladly give is: follow 
your own findings, have a passion 
for science, communicate and share 
your knowledge, and do not be afraid 
to challenge your own thoughts or 
preconceived ideas of any kind.
What has been your biggest mistake 
in research? To spend too much time 
trying to solve the structure of the 
fibroblast growth factor receptor. My 
approaches were not sophisticated 
enough to address this issue and I 
made too many premature decisions 
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CT afferents
India Morrison
What are CT afferents? Nerve 
receptors in mammalian skin that 
respond to innocuous mechanical 
stimulation. Although C afferents as a 
class are associated with temperature 
and pain coding, CT — for ‘C tactile’ 
or ‘tactile C’ — afferents respond to 
light touch but not painful stimulation. 
They fire action potentials when the 
skin is gently deformed, earning 
the classification of ‘low-threshold 
mechanoreceptors’.
Where are they found? Mammals 
have two general types of epidermal 
skin, each with a slightly different 
composition of nerve receptors. Hairy 
skin covers most of the body even 
where the hair is not always prominent, 
as in humans. Glabrous skin is the 
‘smooth’ skin of the palms, soles, 
and lips. CT afferents are found in 
hairy, but not in glabrous skin of all 
mammals investigated: cats, pigs, 
rodents, nonhuman primates, and 
humans. Their response properties are 
independent of the afferent receptors 
associated with hair follicles, though 
early observations in cats indicated 
that CTs can be sensitive to movement 
of hairs. So far, CT afferents have not 
been found in genital skin. 
These low-threshold 
mechanoreceptive C afferents 
were first reported in cats by Ingve 
Zotterman in 1939. For decades it was 
presumed that they did not exist in 
humans, but in 1990 Magnus Nordin 
made microneurography recordings 
of human CTs from the face. Human 
CT receptive fields are also found in 
the arm and in the leg. The receptive 
fields of CT afferents show a patchy 
organization. Tracer evidence from 
transgenic mice confirms that the 
free nerve endings probably have a 
branching, arborized structure. 
What makes CT afferents unique? 
CT afferents are so sensitive to skin 
deformation that touching the skin 
with a force as low as 0.22 grams 
(2.2 milliNewtons, mN) is sufficient 
to elicit high impulse rates. Like 
other types of C afferent nerves, CTs 
Quick guidesalong the way. Nevertheless, I learnt a lot and looking back I feel I needed this 
tough period in my career. 
What is your favourite conference? 
The most recent memorable conference 
was the EMBO meeting on Ubiquitin 
and SUMO in Cavtat/Dubrovnik. It was 
an exciting scientific program, with 
great people giving talks in a fantastic 
atmosphere along the Adriatic Coast. 
Do you have a ‘scientific hero’ — if so, 
who and why? I would mention Max 
Perutz for his influence on my career 
shift from medicine toward molecular 
biology. Reading about his work at 
the time revealed my genuine interest 
toward biology. Perutz was a brilliant 
scientist, a founding member of modern 
molecular biology in Europe and a great 
mentor who knew how to inspire young 
scientists toward pursuing a career in 
science. His book I Wish I’d Made You 
Angry Earlier is a good story about 
science, passion and creative power 
that reveals scientific research to be the 
most exciting profession.
Do you have a ‘favorite’ paper? There 
were several papers that influenced 
my career and way of doing science, 
sparking an intense interest to indulge 
in a new field or just leaving me feeling 
that science is great. It is difficult to 
single one out in particular, but I may 
mention the paper by Kazu Iwai’s group 
published in EMBO J. in 2006, which 
described the existence of a ligase 
complex that can build linear ubiquitin 
chains, a novel type of ubiquitin chain 
conjugated via methionine residues 
in ubiquitin rather than lysines. This 
manuscript greatly influenced our 
work as we solved a structure of a 
domain in the NEMO protein bound to 
linear diubiquitin and the puzzle was 
put together — we could understand 
how linear chains are made and how 
these chains can be recognized in 
cells by their selective receptors. Very 
commonly it is this type of unexpected 
finding that is the most exciting. 
Do you have any strong views on 
journals and the peer review system? 
We try to publish our scientific work 
in the most appropriate journals in the 
field and we depend very much on a fair 
and fast peer review system. The recent 
changes in peer reviewing are often 
characterized by long and unnecessarily 
detailed procedures including several 
rounds of revisions. In such instances the big picture of discoveries tends to 
be lost by unreasonable requests to 
do more and more experiments, not to 
prove the major finding but rather to 
satisfy the new directions imposed by 
the reviewers.
What are your views on 
communication of science to the 
public? Popularization of science is of 
great importance and emphasizing this 
aspect among younger generations of 
students is essential. With the influence 
of modern methods of communication, 
via the broad accessibility of the internet 
to the general public as well as growing 
social networks, scientists have better 
chances than ever to communicate 
about science and to convey the 
necessary messages to the public.
What are your views on science 
education? I consider education of 
students as exciting as science itself. I 
have put great effort into the education 
of students from my homeland Croatia 
via numerous programs. Among them 
was the opening of an outstation lab 
that was supported from my main base 
in Frankfurt. The laboratory opened 
7 years ago and the net results are very 
positive in terms of education, transfer 
of technologies, increased quality of 
publication, and financial assistance for 
talented scientists in Croatia.
What do you think are the big 
questions to be answered next in your 
field? One of the most exciting aspects 
of ubiquitin research is to understand 
how ubiquitin regulates a large 
spectrum of cellular processes. At the 
moment, we are trying to incorporate 
more quantitative and structural biology 
approaches in our research, and I 
believe that these two disciplines will 
be invaluable in providing new insights 
into the regulation of, for example, DNA 
repair, immunity and inflammation and, 
more recently, autophagy, which is a 
cellular self-eating mechanism.
What is your greatest ambition? To 
have fun doing science. It would be nice 
to be a member of the scientific team 
that will reveal the molecular map of 
a living cell, i.e. describing the spatio-
temporal laws of all dynamic changes 
that are governing the cell’s interior.
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